Crestor and Metamorphopsia - a phase IV clinical study of FDA data

Summary:

Metamorphopsia is reported as a side effect among people who take Crestor (rosuvastatin calcium), especially for people who are female, 60+ old, also take Avastin, and have Diabetic retinopathy.

The phase IV clinical study analyzes which people have Metamorphopsia when taking Crestor. It is created by eHealthMe based on reports of 143,349 people who have side effects when taking Crestor from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.

What is Metamorphopsia?

Metamorphopsia (a type of distorted vision in which a grid of straight lines appears wavy and parts of the grid may appear blank) is found to be associated with 212 drugs and 367 conditions by eHealthMe. Check the latest studies of Metamorphopsia.

On Jul, 07, 2026

143,349 people reported to have side effects when taking Crestor.
Among them, 14 people (0.01%) have Metamorphopsia.

Among these 14 people:

What is the gender of people who have Metamorphopsia when taking Crestor? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Metamorphopsia when taking Crestor? *

What are other drugs people take besides Crestor? *

What are other side effects people have besides Metamorphopsia? *

Visual Impairment: 5 people, 35.71%
Visual Acuity Reduced (reduced clearness of vision): 4 people, 28.57%
Vision Blurred: 4 people, 28.57%
Stress And Anxiety: 3 people, 21.43%
Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Dyspnea (difficult or laboured breathing): 3 people, 21.43%
Muscle Spasms (muscle contraction): 3 people, 21.43%
Cardiomyopathy (weakening of the heart muscle): 2 people, 14.29%
Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina): 2 people, 14.29%
Ageusia (loss of taste functions of the tongue): 2 people, 14.29%

What are the existing conditions these people have? *

Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 21.43%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 3 people, 21.43%
High Blood Pressure: 2 people, 14.29%
Pain: 2 people, 14.29%
Weakness: 1 person, 7.14%
Age-Related Macular Degeneration: 1 person, 7.14%
Blood Iron Decreased: 1 person, 7.14%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 7.14%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 7.14%
Diabetic Eye Disease: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and have Metamorphopsia?

- Check whether Metamorphopsia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Crestor:

Crestor (149,761 reports)

Metamorphopsia treatments and more:

Metamorphopsia (2,072 reports)

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metamorphopsia:

Metamorphopsia (212 drugs)

Browse all the conditions that are associated with Metamorphopsia:

Metamorphopsia (367 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Crestor) and Crestor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.